GILD 112.69 ▲ 1.93% Live Trading Data - Stocknear
Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Start Trial

    Gilead Sciences Inc.

    NASDAQ: GILD · Real-Time Price · USD
    112.69
    2.13 (1.93%)
    At close: Oct 03, 2025, 3:59 PM
    112.85
    0.14%
    After-hours: Oct 03, 2025, 07:55 PM EDT
    1.93%
    Bid 110.05
    Market Cap 139.83B
    Revenue (ttm) 28.86B
    Net Income (ttm) 6.31B
    EPS (ttm) 7.74
    PE Ratio (ttm) 14.56
    Forward PE 12.83
    Analyst Buy
    Dividends $3.14
    Ask 114
    Volume 7,891,565
    Avg. Volume (20D) 6,539,796
    Open 110.72
    Previous Close 110.56
    Day's Range 109.66 - 113.59
    52-Week Range 83.98 - 121.83
    Beta 0.35
    Ex-Dividend Date Sep 15, 2025

    About GILD

    undefined

    [Read more]
    Industry n/a
    Sector n/a
    IPO Date n/a
    Employees NaN
    Stock Exchange n/a
    Ticker Symbol GILD
    Website n/a
    Full Company Profile

    Analyst Forecast

    According to 0 analyst ratings, the average rating for GILD stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.

    Stock Forecasts

    Next Earnings Release

    Gilead Sciences Inc. is scheduled to release its earnings on Nov 5, 2025, after market closes.
    Analysts project revenue of ... Unlock content with Pro Subscription
    1 month ago
    +8.28%
    Gilead Sciences shares are trading higher after th... Unlock content with Pro Subscription
    2 months ago
    +2.65%
    Gilead Sciences shares are trading higher after Needham upgraded the stock from Hold to Buy and announced a price target of $133.
    news image

    2 days ago · zacks.com

    Gilead Sciences, Inc. (GILD) Is a Trending Stock: Facts to Know Before Betting on It

    Gilead (GILD) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.

    news image

    4 days ago · seekingalpha.com

    Dividend Shields: Top 5 Income Stocks

    Market optimism has waned as investors weighed mixed data, Fed guidance, and sector-specific risks after the S&P 500 hit eight record highs in September. Strong GDP and jobs data have tempered rate cu...

    news image

    1 week ago · zacks.com

    Gilead Sciences (GILD) Declines More Than Market: Some Information for Investors

    Gilead Sciences (GILD) concluded the recent trading session at $110.99, signifying a -2.36% move from its prior day's close.

    news image

    1 week ago · businesswire.com

    Gilead Foundation Grants $6.5 Million in Commitment to STEM Education

    FOSTER CITY, Calif.--(BUSINESS WIRE)--Gilead Sciences, Inc. (Nasdaq: GILD) today announced that it has committed more than $6.5 million in grant funding toward strengthening science, technology, engin...

    news image

    1 week ago · zacks.com

    Gilead Sciences Surges 26.5% YTD: Buy, Sell or Hold the Stock?

    Gilead surges 26.5% YTD in 2025 as HIV franchise gains momentum with Yeztugo approval, offsetting cell therapy pressures.

    news image

    1 week ago · seekingalpha.com

    Gilead Sciences: Yeztugo And Trodelvy Make This A Buy Once More

    Gilead Sciences is upgraded to 'Buy' as YEZTUGO's FDA approval strengthens its dominant HIV franchise and long-term outlook. GILD's valuation remains attractive, with a P/E of 14.74 and significant up...

    news image

    2 weeks ago · zacks.com

    Investors Heavily Search Gilead Sciences, Inc. (GILD): Here is What You Need to Know

    Gilead (GILD) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

    news image

    2 weeks ago · zacks.com

    Gilead Sciences (GILD) Ascends While Market Falls: Some Facts to Note

    Gilead Sciences (GILD) reached $112.26 at the closing of the latest trading day, reflecting a +1.26% change compared to its last close.

    news image

    3 weeks ago · zacks.com

    Gilead Sciences (GILD) Exceeds Market Returns: Some Facts to Consider

    In the latest trading session, Gilead Sciences (GILD) closed at $117.86, marking a +2.26% move from the previous day.

    news image

    3 weeks ago · seekingalpha.com

    Gilead Sciences, Inc. (GILD) Presents At Baird Global Healthcare Conference 2025 Transcript

    Gilead Sciences, Inc. (NASDAQ:GILD ) Baird Global Healthcare Conference 2025 September 10, 2025 11:25 AM EDT Company Participants Cindy Perettie - Executive Vice President of Kite Conference Call Part...

    Add to Watchlist